90
Participants
Start Date
Not specified
Study Completion Date
June 30, 2005
Selegiline hydrochloride
Mount Sinai Med Ctr, New York
Columbia Presbyterian Med Ctr, New York
Univ of Rochester Medical Center, Rochester
Univ of Pennsylvania, Philadelphia
Johns Hopkins Hosp, Baltimore
UCLA CARE Ctr, Los Angeles
Univ of California, San Diego, San Diego
Univ of Washington, Seattle
Stanford University, Stanford
Rhode Island Hosp, Providence
Stanley Street Treatment and Resource, Providence
The Miriam Hosp, Providence
National Institute of Allergy and Infectious Diseases (NIAID)
NIH